Skip to main content
CivicGate

← Organizations

Fresenius Medical Care North America

lobbying client · lobbying firm

Fresenius Medical Care North America's federal footprint — reported lobbying spend and, where matched, federal money received. Figures are as reported to the U.S. Senate (LDA) and USAspending.

Lobbying from Senate LDA

Reported lobbying (spent)$30,410,000
Years coveredFY2022–FY2025
Reported lobbying billed / handled $25,170,000
Firm activeFY2022–FY2025

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Fresenius Medical Care North America per filing year
FYLobbying spend (as client)Lobbying billed / handled (as firm)
2022$8,880,000$7,330,000
2023$8,160,000$6,700,000
2024$7,660,000$6,510,000
2025$5,710,000$4,630,000

Two figures: what Fresenius Medical Care North America reported spending on its own lobbying (as a client) and what it billed or handled for the clients it represents (as a firm — revenue, not its own spend). For a self-filer these overlap.

Firms hired

  • Avenue Solutions $960,000 · 16 filings
  • Federal Health Policy Strategies $960,000 · 16 filings
  • Tiber Creek Health Strategies, INC. $960,000 · 16 filings
  • Penn Avenue Partners $770,000 · 16 filings
  • Miller Strategies, LLC $640,000 · 16 filings
  • East End Group, LLC $450,000 · 10 filings
  • The Gibson Group, LLC $320,000 · 16 filings
  • Bloom Strategic Counsel $180,000 · 9 filings

Registrants that filed lobbying on behalf of Fresenius Medical Care North America.

Clients represented

Self-filed — Fresenius Medical Care North America registers and lobbies on its own behalf, with no separate outside clients.

Issues

Issue area Lobbied Worked
Medicare/Medicaid 77 16
Health Issues 71
Immigration 16
Labor Issues/Antitrust/Workplace 12
Tariff (miscellaneous tariff bills) 4 4

Issue areas across Fresenius Medical Care North America's filings, by activity count — as the client (Lobbied) and as the registrant/firm (Worked). Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

  • FY2025 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

    H.R. 2199 S. 1173 H.R. 1 H.Con.Res. 14

  • FY2025 Medicare/Medicaid self-filed

    H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act H.R. 1 The Budget Reconciliation bill - the "One Big, Beautiful Bill" Act. - Medicaid changes H.R.3944 The Military Construction, Veterans Affairs, and Related Agencies Appropriations Act for Fiscal Year 2025 (FY25). The Kidney Care Access Protection Act (no bill number) End-Stage Renal Disease (ESRD) Prospective Payment System (PPS)

    H.R. 2199 S. 1173 H.R. 1 H.R. 3944

  • FY2025 Tariff (miscellaneous tariff bills) self-filed

    Tariffs

  • FY2025 Health Issues as client

    Monitor competition in the kidney dialysis market Monitor VA contracting system for kidney dialysis Monitor telehealth issues Monitor issues relating to Medicare Secondary Payer legislation

  • FY2025 Immigration as client

    Monitor H1-B visas Monitor issues related to high-skilled immigration

  • FY2025 Health Issues as client

    Policy issues related to end state renal disease.

  • FY2025 Medicare/Medicaid as client

    Issues as they relate to the Medicare ESRD Program, charitable premium assistance, and healthcare reform.

  • FY2025 Health Issues as client

    Policy issues related to end state renal disease. H.R.1 - One Big Beautiful Bill Act. H.R.2199/S.1173 - Restore Protections for Dialysis Patients Act.

    H.R. 1 H.R. 2199 S. 1173

Show 52 more activities
  • FY2025 Medicare/Medicaid self-filed

    H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act Implementation of the "One Big, Beautiful Bill" Act.-P.L. 119-21 The VA/MILCON Appropriations Subcommittee bill. H.R. 6214/S. 2730 - Kidney Care Access Protection Act Medicare and Medicaid coverage End Stage Renal Disease (ESRD) Prospective Payment System (PPS) Kidney Care Choices Model and Skin Substitutes

    H.R. 2199 S. 1173 H.R. 6214 S. 2730

  • FY2025 Tariff (miscellaneous tariff bills) self-filed

    Tariffs

  • FY2025 Medicare/Medicaid as client

    Issues as they relate to the Medicare ESRD Program, charitable premium assistance, and healthcare reform.

  • FY2025 Health Issues as client

    Monitor competition in the kidney dialysis market VA contracting system for kidney dialysis Monitor telehealth issues Monitor issues relating to Medicare Secondary Payer legislation

  • FY2025 Immigration as client

    Monitor H1-B visas Monitor issues related to high-skilled immigration

  • FY2025 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

    H.R. 2199 S. 1173 S. 2730

  • FY2025 Health Issues as client

    Expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTCs)

  • FY2025 Medicare/Medicaid as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Health Issues as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Medicare/Medicaid as client

    Issues as they relate to the Medicare ESRD Program, charitable premium assistance, and healthcare reform.

  • FY2025 Medicare/Medicaid as client

    Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Health Issues as client

    Monitor competition in the kidney dialysis market Monitor VA contracting system for kidney dialysis Monitor telehealth issues Monitor issues relating to Medicare Secondary Payer legislation

  • FY2025 Immigration as client

    Monitor H1-B visas Monitor issues related to high-skilled immigration

  • FY2025 Medicare/Medicaid as client

    Issues related to Medicare reimbursement.

  • FY2025 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

    H.R. 2199 S. 1173 S. 2730

  • FY2025 Health Issues as client

    Expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTCs)

  • FY2025 Health Issues as client

    Policy issues related to end state renal disease.

  • FY2025 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

    H.R. 2199 S. 1173 S. 891 H.R. 1968

  • FY2025 Medicare/Medicaid as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Health Issues as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Health Issues as client

    Policy issues related to end state renal disease.

  • FY2025 Medicare/Medicaid self-filed

    H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act Tariffs

    H.R. 2199 S. 1173

  • FY2025 Tariff (miscellaneous tariff bills) self-filed

    H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act Tariffs

    H.R. 2199 S. 1173

  • FY2025 Medicare/Medicaid self-filed

    H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act The Budget Reconciliation bill - the "One Big, Beautiful Bill" Act.-P.L. 119-21 The VA/MILCON Appropriations Subcommittee bill. S. 2730 - Kidney Care Access Protection Act Medicare and Medicaid coverage End Stage Renal Disease (ESRD) Prospective Payment System (PPS)

    H.R. 2199 S. 1173 S. 2730

  • FY2025 Tariff (miscellaneous tariff bills) self-filed

    Tariffs

  • FY2025 Medicare/Medicaid as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Health Issues as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Medicare/Medicaid as client

    Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Health Issues as client

    Competition in the kidney dialysis market Monitor VA contracting system for kidney dialysis Monitor telehealth issues Monitor issues relating to Medicare Secondary Payer legislation

  • FY2025 Immigration as client

    Monitor H1-B visas Monitor issues related to high-skilled immigration

  • FY2025 Medicare/Medicaid as client

    Issues as they relate to the Medicare ESRD Program, charitable premium assistance, and healthcare reform.

  • FY2025 Medicare/Medicaid as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Health Issues as client

    Issues impacting coverage of end-stage renal disease.

  • FY2025 Medicare/Medicaid as client

    Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2024 Medicare/Medicaid self-filed

    H.R. 6860 - Restore Protections for Dialysis Patients Act H.R. 5074 - Kidney PATIENT Act of 2023 H.R.5027 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 H.R.5027 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 Dialysis preparedness planning Dialysis services for the Veterans Administration

    H.R. 6860 H.R. 5074 H.R. 5027

  • FY2024 Health Issues as client

    Competition issues in the kidney dialysis market. VA contracting system for kidney dialysis. Monitor issues related to oral-only ESRD drugs. Monitor issues relating to the physician fee schedule rule. Monitor telehealth issues. Monitor issues relating to accreditation of dialysis facilities. Monitor issues relating to Medicare reimbursement for dialysis vascular access services. Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs). Monitor issues relating to ESRD Treatment Choices Model. Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage. Monitor Issues relating to Medicare Secondary Payer legislation.

  • FY2024 Immigration as client

    Monitor H1-B Visas. Monitor issues relating to high-skilled immigration.

  • FY2024 Health Issues as client

    Competition issues in the kidney dialysis market. Monitor VA contracting system for kidney dialysis. Monitor issues related to oral-only ESRD drugs. Monitor issues relating to the physician fee schedule rule. Monitor telehealth issues. Monitor issues relating to accreditation of dialysis facilities. Monitor issues relating to VA contracting with dialysis facilities. Monitor issues relating to Medicare reimbursement for dialysis vascular access services. Monitor issues relating to Medicare reimbursement for ESRD Seamless Care Organizations (ESCOs). Monitor issues relating to ESRD Treatment Choices Model. Monitor Issues relating network adequacy standards for kidney dialysis under Medicare Advantage. Monitor Issues relating to Medicare Secondary Payer legislation.

  • FY2024 Immigration as client

    Monitor H1-B Visas. Monitor issues relating to high-skilled immigration.

  • FY2024 Medicare/Medicaid as client

    H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.

    H.R. 5027 S. 4469 H.R. 6860 S. 5018 H.R. 5074

  • FY2024 Health Issues as client

    H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074 Kidney Patient Act of 2024, issues related to CY 2025 CMS final rule for ESRD PPS and Quality Improvement Program.

    H.R. 5027 S. 4469 H.R. 6860 S. 5018 H.R. 5074

  • FY2024 Medicare/Medicaid self-filed

    H.R.6860/ S. 5018 Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, Kidney Patient Act of 2023 H.R. 8594 - Restore Protections for Dialysis Patients Act, all provisions S. 4750 - Restore Protections for Dialysis Patients Act, all provisions H.R.5027 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

    H.R. 6860 S. 5018 H.R. 5074 S. 4510 H.R. 8594 S. 4750 H.R. 5027

  • FY2024 Medicare/Medicaid self-filed

    H.R.6860 - Restore Protections for Dialysis Patients Act H.R.5074 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments H.R.5027 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 Dialysis preparedness planning

    H.R. 6860 H.R. 5074 H.R. 5027

  • FY2024 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023

    H.R. 6860 H.R. 5027 S. 4469 H.R. 5074 S. 4510

  • FY2024 Health Issues as client

    Policy issues related to end state renal disease.

  • FY2024 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23); Challenges associated with CMMI Kidney Models; H.R. 5074, Kidney PATIENT Act of 2023

    H.R. 6860 H.R. 5027 H.R. 5074

  • FY2024 Health Issues as client

    Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

    H.R. 4366 H.R. 2882

  • FY2024 Medicare/Medicaid as client

    Issues as they relate to the Medicare ESRD Program, charitable premium assistance, and healthcare reform.

  • FY2024 Health Issues as client

    Policy issues related to end state renal disease.

  • FY2024 Medicare/Medicaid as client

    Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 10545, American Relief Act, 2025

    H.R. 6860 S. 5018 H.R. 5027 S. 4469 H.R. 5074 S. 4510 H.R. 10545

  • FY2024 Medicare/Medicaid as client

    Issues related to Medicare reimbursement.

  • FY2024 Medicare/Medicaid as client

    Issues related to Medicare reimbursement.

The specific issues and bills Fresenius Medical Care North America reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.